Ads
related to: pharmaceutical industry analysis
Search results
From Hype To Reality, AI Reshapes Pharmaceutical Industry Across Drug Discovery To Marketing -...
Benzinga via Yahoo Finance· 2 hours agoPharmaceutical companies have been at the forefront of artificial intelligence for quite some time....
Earnings call: PolyPid reports progress in D-PLEX100 trial, eyes expansion By Investing.com
Investing.com· 3 hours agoPolyPid Ltd. (NASDAQ:PYPD), a specialty pharmaceutical company, announced its first-quarter...
Supernus Pharmaceuticals First Quarter 2024 Earnings: EPS: US$0.002 (vs US$0.31 in 1Q 2023)
Simply Wall St. via Yahoo Finance· 12 hours agoThe company's share price is broadly unchanged from a week ago. Balance Sheet Analysis Just as...
Collegium Pharmaceutical, Inc.'s (NASDAQ:COLL) CEO Looks Like They Deserve Their Pay Packet
Simply Wall St. via Yahoo Finance· 12 hours agoThat's a notable increase of 32% on last year. We think total compensation is more important but our...
Tarsus Pharmaceuticals First Quarter 2024 Earnings: Beats Expectations
Simply Wall St. via Yahoo Finance· 11 hours agoEarnings per share (EPS) also surpassed analyst estimates by 15%. Looking ahead, revenue is forecast...
Earnings call: Cipher Pharmaceuticals reports strong Q1 with revenue up 20% By Investing.com
Investing.com· 5 hours agoCipher Pharmaceuticals (OTC:CPHRF) Inc. (TSX:CPH) has released its Q1 2024 financial results,...
Ironwood Pharmaceuticals First Quarter 2024 Earnings: US$0.03 loss per share (vs US$0.30 profit in...
Simply Wall St. via Yahoo Finance· 9 hours agoNasdaqGS:IRWD Earnings and Revenue Growth May 10th 2024 IronwoodPharmaceuticals Earnings Insights...
Teva Pharmaceutical Industries First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
Simply Wall St. via Yahoo Finance· 1 day agoEarnings per share (EPS) missed analyst estimates by 149%. Looking ahead, revenue is forecast to...
Earnings call: Ironwood Pharmaceuticals reports robust Q1 growth By Investing.com
Investing.com· 1 hour agoIronwood Pharmaceuticals, Inc. (NASDAQ: IRWD) provided an update on its financial and operational...
Here's What Analysts Are Forecasting For Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) After Its...
Simply Wall St. via Yahoo Finance· 6 days agoFactoring in the forecast slowdown in growth, it looks like Ultragenyx Pharmaceutical is forecast to...